CClinicalTrials.gg
CompletedNCT03443258NEATUpdated Oct 9, 2020

Needs Assessment Tool Integrated in Clinical Practice of Head and Neck Cancer Rehabilitation

An interventional study of Needs assesment tool integrated in nursing consultation. in Head and Neck Neoplasms, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2020-10-09.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
93
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Study summary

The study tests a needs assessment and decision-making tool with patients who are in need of rehabilitation after surgery for Head and Neck Cancer. The purpose is to enhance patient involvement in decision-making.

Read the detailed description

The study tests a needs assessment and decision-making tool with patients surgically treated for Head and Neck Cancer. The tool will be an integrated part of a new clinical practice with nursing consultations at three seperate time-points in the post-surgical period of the patients. Half of the participants will receive nursing consultations using the tool and the other half will receive standard care.

02

Conditions studied

  • Head and Neck Neoplasms
03

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical diagnosis of Head and Neck Cancer
  • Stage T3 or T4
  • Surgically treated
  • Must be able to speak and understand Danish

Exclusion criteria

Exclusion Criteria:

  • Treated surgically for thyroid or parotic cancers
  • Referred to adjuvant radio - or chemotherapy
  • Having an unstable psychiatric illness.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
93 participants (actual)

Study arms

  • Experimental
    Intervention Group (IG)

    Patients receive needs assessment tool integrated in nursing consultation in accordance with requirements by Danish Health and Medicine Board follow-up program for HNC patients. The consultation consists of 6 steps 1. Welcoming patient; 2. Introducing patient to assessment tool; 3. Discuss symptoms and concerns patient wishes to discuss; 4. Follow up on patients symptoms, concerns and emotional reactions/problems; 5. Accompany/support patient during appointment with surgeon and in cooperation with patient and surgeon ensure that problems arising from the tool needing medical attention are focused on; 6. Continue the consultation after appointment with surgeon; refer patient to multi-disciplinary team members when needed

    Other: Needs assesment tool integrated in nursing consultation.

  • No intervention
    Control Group (CG)

    CG will receive standard care according to the Danish Health and Medicine Board's follow-up program for HNC patients. At present this is done by a staff nurse interviewing the patient, who is a member of the rehabilitation team who perform nursing consultations. The interview takes place after the appointment with the surgeon. The nurse refers the patient to physical rehabilitation if needed

Interventions

  • OtherNeeds assesment tool integrated in nursing consultation.

    Needs assessment tool consisting of 57 items related to functional, emotional, social and existential areas guide follow-up care and referral to multidisciplinary team rehabilitation e.g. dietician; speech-pathologist; psychologist, etc

05

What researchers measure

Primary outcomes

  1. Change in Health Related Quality of Life, from baseline to 9, 21 and until 67 days post surgery

    Questionnaire measuring 35 items related to quality of life in head and neck cancer. European Organisation for Research and Treatment of Cancer Quality of Life and Head and Neck Cancer (EORTC QLQ-H\&N35). Scores range from 0 - 100,, where a high score represents high quality of life. The study will measure global quality of life

    Time frame: Baseline; 9; 21 and 67 days post-surgery

Secondary outcomes

  1. Change in Symptom Burden from baseline to 2, 14 and 60 days post-surgery

    Questionnaire measuiring 28 items related to symptoms of head and neck cancer patients. MD Anderson Symptom Inventory Head and Neck Cancer module (MDASI-HN). Scores range from 0 - 10, where a high score represents a high symptom burden interference with daily life.

    Time frame: Baseline, 2, 14 and 60 days post-surgery

06

Study locations

1 site
  • Dept. Of Otorhinolaryngology, Head and Neck Surgery and Audiology
    Copenhagen, Denmark
07

References and documents

Publications

  • Mortensen A, Wessel I, Rogers SN, Tolver A, Jarden M. Needs assessment in patients surgically treated for head and neck cancer-a randomized controlled trial. Support Care Cancer. 2022 May;30(5):4201-4218. doi: 10.1007/s00520-021-06759-9. Epub 2022 Jan 27. PubMed 35083545 ↗

Study documents

  • Study protocol · Jan 31, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03443258
Lead sponsor
Rigshospitalet, Denmark
Collaborators
Novo Nordisk A/S, Danish Nurses Organisation
Responsible party
Annelise Mortensen (PhD student, Rigshospitalet, Denmark) — Principal investigator
First posted
Feb 23, 2018
Start date
Jun 11, 2018
Primary completion
Nov 15, 2019
Completion
Nov 30, 2019
Last update
Oct 9, 2020

Study contacts

Annelise Mortensen, MSA
principal investigator · Rigshospitalet, Denmark

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion